Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TELA Bio (TELA) Equity Ratio (2018 - 2026)

TELA Bio has reported Equity Ratio over the past 8 years, most recently at 0.08 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 76.41% year-over-year to 0.08; the TTM value through Dec 2025 reached 0.08, down 76.41%, while the annual FY2025 figure was 0.08, 76.41% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.08 at TELA Bio, up from 0.03 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.53 in Q1 2021 and troughed at 0.12 in Q3 2024.
  • A 5-year average of 0.22 and a median of 0.22 in 2022 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: skyrocketed 1510.97% in 2023 and later plummeted 133.81% in 2024.
  • Year by year, Equity Ratio stood at 0.32 in 2021, then plummeted by 34.39% to 0.21 in 2022, then grew by 14.75% to 0.24 in 2023, then surged by 35.89% to 0.33 in 2024, then crashed by 76.41% to 0.08 in 2025.
  • Business Quant data shows Equity Ratio for TELA at 0.08 in Q4 2025, 0.03 in Q3 2025, and 0.14 in Q2 2025.